Enhanced Security for Jockey Club Gold Cup
The Blood-Horse Staff
September 20, 2013
Horses competing in the race will be subject to early out-of-competition blood testing for banned substances.
Horses competing in the race will be subject to early out-of-competition blood testing for banned substances.
Officials adopted uniform medication and drug-testing rules as part of a push in the Mid-Atlantic region.
Officials announced the total ban on anabolic steroid use, both in and out of competition, on Sept 16.
The group aims to help participants adhere to Clean Sport’ standards and code of conduct for horse welfare.
Among the measures is early out-of-competition blood testing for banned substances.
KHRC Medical Director Mary Scollay, DVM, gave an introduction to the Mid-Atlantic Uniform Medication Program.
Panelists said public perception is based on biased representation by press and industry organizations.
The Jockey Club recommended that all U.S. racing jurisdictions pledge to adopt a uniform medication program.
The Jockey Club will provide funds to some racing jurisdictions to step up out-of-competition drug testing.
The BHA concluded its investigation into “Sungate,” a veterinary product which contains an anabolic steroid.
RCI voted to approve model rules that create a points system and enhanced penalties for drug violations.
An official explains why confidentiality is used when setting medication thresholds and withdrawal times.
Regulatory administration of race-day anti-bleeding medication has provided a clearer picture of drug testing.
The Kentucky Horse Racing Commission approved a “rapid response” protocol to examine emerging illegal drugs.
The model rule represents a plan to provide appropriate penalties for violations of medication regulations.
The regulations are a “living document” that likely will be adjusted based on industry needs, one group says.
Stay on top of the most recent Horse Health news with
